Photon-Counting Detector CT for Musculoskeletal Imaging: A Clinical Perspective.

J. Fletcher,S. Leng,A. Ferrero,K. Glazebrook,Francis I Baffour,C. McCollough,K. Rajendran
DOI: https://doi.org/10.2214/AJR.22.28418
2022-10-19
Abstract:Photon-counting detector (PCD) CT has emerged as a novel imaging modality that represents a fundamental shift in the way that CT systems detect X-rays. Following preclinical and clinical investigations showing benefits of PCD CT for a range of imaging tasks, the first commercial PCD CT system was approved by the U.S. FDA for clinical use in 2021. The technologic features of PCD CT are particularly well suited for musculoskeletal imaging applications. Advantages of PCD CT compared with conventional energy-integrating detector CT include smaller detector pixels and excellent geometric dose efficiency that enable ultra-high-spatial resolution imaging of large joints and central skeletal anatomy; advanced multi-energy spectral postprocessing that allows quantification of gouty deposits and generation of virtual non-calcium images to visualize bone edema; improved metal artifact reduction for imaging of orthopedic implants; as well as higher CNR and suppression of electronic noise. Given substantially improved cortical and trabecular detail, PCD CT images more clearly depict skeletal pathologies including fractures, lytic lesions, and mineralized tumor matrix. This article reviews the technical features of PCD CT and their associated impact for musculoskeletal imaging applications, using clinical examples to compare EID CT and PCD CT.
Medicine,Engineering
What problem does this paper attempt to address?